The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that can cause side ...
High-frequency trading (HFT) firm Flow Traders has been handed formal regulatory approval in Japan to operate a high-speed trading business. The Financial Services Agency of Japan (FSA) registered the ...
By Kamal Choudhury Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical ...
Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in treating depression, a regulatory milestone that could reshape a mental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results